{"id":"https://openalex.org/W2896869398","doi":"https://doi.org/10.1158/1538-7445.pedca17-ia08","title":"Abstract IA08: Epigenetic mechanisms of resistance to targeted therapy","display_name":"Abstract IA08: Epigenetic mechanisms of resistance to targeted therapy","publication_year":2018,"publication_date":"2018-10-01","ids":{"openalex":"https://openalex.org/W2896869398","doi":"https://doi.org/10.1158/1538-7445.pedca17-ia08","mag":"2896869398"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.pedca17-ia08","doi":"https://doi.org/10.1158/1538-7445.pedca17-ia08","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.pedca17-ia08","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002000126","display_name":"Rani E. George","orcid":"https://orcid.org/0000-0003-4206-1779","observed_orcids":["https://orcid.org/0000-0003-4206-1779"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rani E. George","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5002000126"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"19_Supplement","first_page":"IA08","last_page":"IA08"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9110999703407288,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.9110999703407288,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.046300001442432404,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alk-inhibitors","display_name":"ALK inhibitors","score":0.8650000095367432},{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.8080000281333923},{"id":"https://openalex.org/keywords/mycn-amplification","display_name":"MYCN amplification","score":0.9089999794960022},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.9769999980926514},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chromatin-remodeling","display_name":"chromatin remodeling","score":0.9959999918937683},{"id":"https://openalex.org/keywords/transcription-factors","display_name":"transcription factors","score":0.8730000257492065},{"id":"https://openalex.org/keywords/epigenetic-mechanisms","display_name":"epigenetic mechanisms","score":0.8759999871253967},{"id":"https://openalex.org/keywords/targeted-therapy-resistance","display_name":"targeted therapy resistance","score":0.8799999952316284}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7107176780700684},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.6627280116081238},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5828555822372437},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.5365486145019531},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4942021667957306},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.4741855561733246},{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.46977871656417847},{"id":"https://openalex.org/C2780737395","wikidata":"https://www.wikidata.org/wiki/Q18353741","display_name":"Epigenetic therapy","level":5,"score":0.4595462679862976},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.41422879695892334},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4138338565826416},{"id":"https://openalex.org/C83640560","wikidata":"https://www.wikidata.org/wiki/Q180951","display_name":"Chromatin","level":3,"score":0.4105437099933624},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3587561845779419},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.26785269379615784},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2452053725719452},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20663753151893616},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.20360606908798218},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.19920498132705688},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.16013658046722412},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.15383756160736084},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1332721710205078},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.11585083603858948},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.1042206883430481},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.pedca17-ia08","doi":"https://doi.org/10.1158/1538-7445.pedca17-ia08","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.pedca17-ia08","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2953796047","https://openalex.org/W2394880936","https://openalex.org/W1589716509","https://openalex.org/W3217761460","https://openalex.org/W2980391412","https://openalex.org/W4281784644","https://openalex.org/W2144615523","https://openalex.org/W2739957826","https://openalex.org/W4280613292","https://openalex.org/W2765129546"],"abstract_inverted_index":{"Abstract":[0],"Targeted":[1],"cancer":[2],"therapies,":[3],"such":[4],"as":[5],"inhibitors":[6,46,74],"of":[7,27,42,65,78,83,148,156],"the":[8,25,58,63,92,129,157,168],"ALK":[9,45,51,73],"receptor":[10],"tyrosine":[11],"kinase,":[12],"have":[13,38],"yielded":[14],"promising":[15],"outcomes":[16],"in":[17,47,62,88],"patients":[18],"whose":[19],"tumors":[20],"aberrantly":[21],"express":[22],"ALK,":[23],"yet":[24],"development":[26],"resistance":[28,43,71,104,149],"invariably":[29],"limits":[30],"their":[31],"efficacy.":[32],"To":[33],"address":[34],"this":[35,133],"issue,":[36],"we":[37,68],"investigated":[39],"potential":[40],"mechanisms":[41,147],"to":[44,72,101,117,150,167],"neuroblastoma":[48],"cells":[49,56,90],"expressing":[50,57,91],"point":[52],"mutations.":[53],"In":[54],"tumor":[55,89],"ALKF1174L":[59],"mutant":[60],"kinase":[61],"absence":[64],"MYCN":[66,98],"amplification,":[67,103],"observed":[69],"that":[70],"develops":[75],"through":[76,106],"activation":[77],"MAPK":[79],"signaling":[80],"and":[81,115],"induction":[82],"epithelial-to-mesenchymal":[84],"transition.":[85],"By":[86],"contrast,":[87],"same":[93],"mutation":[94],"but":[95],"with":[96,136],"concomitant":[97],"overexpression":[99],"due":[100],"genomic":[102],"arises":[105],"a":[107,118],"different":[108],"mechanism,":[109],"characterized":[110],"by":[111],"extensive":[112],"chromatin":[113],"remodeling":[114],"conversion":[116],"stem":[119],"cell-like":[120],"state.":[121],"I":[122],"will":[123],"describe":[124],"our":[125],"latest":[126],"insights":[127],"into":[128],"molecular":[130],"details":[131],"underlying":[132],"latter":[134],"mechanism":[135],"emphasis":[137],"on":[138],"transcriptional":[139],"regulators.":[140],"Citation":[141],"Format:":[142],"Rani":[143],"E.":[144],"George.":[145],"Epigenetic":[146],"targeted":[151],"therapy":[152],"[abstract].":[153],"In:":[154],"Proceedings":[155],"AACR":[158],"Special":[159],"Conference:":[160],"Pediatric":[161],"Cancer":[162,178],"Research:":[163],"From":[164],"Basic":[165],"Science":[166],"Clinic;":[169],"2017":[170],"Dec":[171],"3-6;":[172],"Atlanta,":[173],"Georgia.":[174],"Philadelphia":[175],"(PA):":[176],"AACR;":[177],"Res":[179],"2018;78(19":[180],"Suppl):Abstract":[181],"nr":[182],"IA08.":[183]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-10-26T00:00:00"}